INSPInspire Medical Systems, Inc.

NYSE inspiresleep.com


$ 145.80 $ 7.24 (5.22 %)    

Tuesday, 16-Jul-2024 15:59:56 EDT
QQQ $ 496.22 $ 0.19 (0.04 %)
DIA $ 409.69 $ 7.30 (1.81 %)
SPY $ 564.93 $ 3.33 (0.59 %)
TLT $ 94.14 $ 1.31 (1.41 %)
GLD $ 228.28 $ 4.46 (1.99 %)
$ 145.82
$ 138.27
$ 0.00 x 0
$ 0.00 x 0
$ 138.27 - $ 147.71
$ 123.27 - $ 328.70
581,167
na
4.32B
$ 1.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-09-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-15-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 06-07-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-buy-on-inspire-medical-systems-lowers-price-target-to-217

Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price tar...

 morgan-stanley-maintains-overweight-on-inspire-medical-systems-lowers-price-target-to-210

Morgan Stanley analyst Kallum Titchmarsh maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and lowers the pric...

 fda-labels-inspire-medicals-sleep-apnea-nerve-stimulator-recall-as-most-serious

Inspire Medical Systems recalls Model 3028 IPG due to manufacturing defect causing serious health risks. Learn about the FDA Cl...

 us-fda-says-inspire-medical-systems-removes-inspire-iv-implantable-pulse-generator-due-to-manufacturing-defect-that-can-result-in-system-malfunctions-fda-says-recall-as-the-most-serious-type

- Reuters

 stifel-maintains-hold-on-inspire-medical-systems-lowers-price-target-to-170

Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price target from $21...

 b-of-a-securities-maintains-neutral-on-inspire-medical-systems-lowers-price-target-to-185

B of A Securities analyst Bob Hopkins maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and lowers the price targ...

 jim-cramer-celestica-makes-a-comeback-sell-this-movie-theater-stock

Jim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported better-than-expected first-quarter...

 piper-sandler-maintains-overweight-on-inspire-medical-systems-raises-price-target-to-255

Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price targe...